Dimensional Fund Advisors Increases Stake in Eli Lilly

Institutional investor raises position in pharmaceutical giant by 2% in Q3

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

Dimensional Fund Advisors LP, a major institutional investor, increased its stake in Eli Lilly and Company (NYSE:LLY) by 2% in the third quarter of 2026, according to a recent 13F filing with the Securities & Exchange Commission. The firm now owns 3,763,922 shares of the pharmaceutical company's stock, making it one of Eli Lilly's largest shareholders.

Why it matters

Eli Lilly is one of the world's leading pharmaceutical companies, known for developing innovative drugs and therapies. Institutional investors like Dimensional Fund Advisors closely monitor and adjust their positions in major healthcare stocks like Eli Lilly, which can signal broader market trends and investor sentiment around the company.

The details

According to the 13F filing, Dimensional Fund Advisors purchased an additional 73,658 shares of Eli Lilly during the third quarter, increasing its total position to approximately 0.4% of the company's outstanding stock. The investment firm cited Eli Lilly's strong pipeline of new drugs and therapies as a key factor behind its increased stake.

  • Dimensional Fund Advisors filed its 13F report for the third quarter of 2026 on March 4, 2026.

The players

Dimensional Fund Advisors LP

A global investment management firm that oversees over $600 billion in assets, with a focus on factor-based and systematic investment strategies.

Eli Lilly and Company

A multinational pharmaceutical company headquartered in Indianapolis, Indiana, known for developing innovative drugs and therapies across a range of therapeutic areas.

Got photos? Submit your photos here. ›

The takeaway

Eli Lilly's continued appeal to major institutional investors like Dimensional Fund Advisors underscores the company's strong position in the pharmaceutical industry and its potential for future growth. As Eli Lilly advances its drug pipeline and navigates industry trends, investors will closely monitor how the company's performance and strategic decisions impact its stock price and shareholder value.